DixonRE. Effect of infections on hospital care. Ann Intern Med1978;89:749–753.
2.
JaySJ. Nosocomial infections. Med Clin North Am1983;67:1251–1277.
3.
HaleyRW, CulverDH, WhiteJW, MorganM, EmoriTG. The nationwide nosocomial infection rate: A new need for vital statistics. Am J Epidemiol1985;121:159–167.
4.
GrossPA, NeuHC, AswapokeeP, Van AntwerpenC, AswapokeeN.Deaths from nosocomial infections: Experience in a university hospital and a community hospital. Am J Med1980;68:219–223.
5.
LaForceFM. Hospital-acquired gram-negative rod pneumonias: An overview. Am J Med1981;70:664–669.
6.
StoutenbeekCP, Van SaeneHKF, MirandaDR, ZandstraDF, LangrehrD.The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. J Trauma1987;27:357–364.
7.
PodnosSD, ToewsGB, PierceAK. Nosocomial pneumonia in patients in intensive care units. West J Med1985;143:622–627.
8.
SeidenfeldJJ, PohlDF, BellRC, HarrisGD, JohansonWG. Incidence, site, and outcome of infections in patients with adult respiratory distress syndrome. Am Rev Respir Dis1986;134:12–16.
9.
StevensRM, TeresD, SkillmanJJ, FeingoldDJ. Pneumonia in an intensive care unit. Arch Intern Med1974;134:106–111.
10.
Ruiz-SantanaS, JimenezAG, EstabanA, . ICU pneumonias: A multi-institutional study. Crit Care Med1987;15:930–932.
11.
CraigCP, ConnellyS.Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control1984;12:233–238.
12.
StammWE, MartinSM, BennettJV. Epidemiology of nosocomial infections due to gram-negative bacilli: Aspects relevant to development and use of vaccines. J Infect Dis1977;136:S151–S160.
PotgieterPD, LintonDM, OliverS, ForderAA. Nosocomial infections in a respiratory intensive care unit. Crit Care Med1987;15:495–498.
17.
HuxleyEJ, ViroslavJ, GrayWR, PierceAK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med1978;64:564–568.
18.
JohansonWGJr, PierceAK, SanfordJP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med1969;281:1137–1140.
19.
LaForceFM, HopkinsJ, TrowR, WangWLL. Human oral defenses against gram-negative rods. Am Rev Respir Dis1976;114:929–935.
20.
WoodsDE. Role of fibronectin in the pathogenesis of gram-negative bacillary pneumonia. Rev Infect Dis1987;9:S386–S390.
21.
JohansonWGJr, PierceAK, SanfordJP, ThomasGD. Nosocomial respiratory infections with gram-negative bacilli. Ann Intern Med1972;77:701–706.
22.
JohansonWGJr, HigushiJH, ChaudhuriTR, . Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis1980;121:55–63.
23.
ProctorRA. Fibronectin: A brief overview of its structure, function, and physiology. Rev Infect Dis1987;9:S317–S321.
24.
ProctorRA. Fibronectin: An enhancer of phagocyte function. Rev Infect Dis1987;9:S412–S419.
25.
Dal NogareAR, ToewsGB, PierceAK. Increased salivary elastase precedes gram-negative bacillary colonization in postoperative patients. Am Rev Respir Dis1987;135:671–675.
26.
NiedermanMS, MerrillWW, FerrantiRD, . Nutritional status and bacterial binding in the lower respiratory tract in patients with chronic tracheostomy. Ann Intern Med1984;100:795–800.
27.
MartinTR. The relationship between malnutrition and lung infections. Clin Chest Med1987;8:359–372.
28.
DriksMR, CravenDE, CelliBR, . Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: The role of gastric colonization. N Engl J Med1987;317:1376–1382.
29.
PingletonSK, HinthornDR, LiuC.Enteral nutrition in patients receiving mechanical ventilation. Multiple sources of tracheal colonization include the stomach. Am J Med1986;80:827–832.
30.
EspositoAL. The effect of common pharmacologic agents on pulmonary antibacterial defenses: Implications for the geriatric patient. Clin Chest Med1987;8:373–380.
GreenGM, JakabGJ, LowRB, DavisGS. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis1977;115:479–514.
33.
EspositoAL. Aspirin impairs antibacterial mechanisms in experimental pneumococcal pneumonia. Am Rev Respir Dis1984;130:857–862.
34.
NelsonS, SummerWR, JakabGJ. Aminophylline-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis1985;131:923–927.
35.
WhiteJC, LanserME, NelsonS, JakabGJ. Methylprednisolone impairs the bactericidal activity of alveolar macrophages. J Surg Res1985;39:46–52.
36.
FormanHJ, NelsonJ.Effect of extracellular calcium on superoxide release by rat alveolar macrophages. J Appl Physiol1983;54:1249–1253.
37.
AstryCL, WarrGA, JakabGJ. Impairment of polymorphonuclear leukocyte immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis1983;128:113–117.
38.
NelsonS, SummerWR, TerryPB, WarrGA, JakabGJ. Erythromycin-induced suppression of pulmonary antibacterial defenses: A potential mechanism of superinfection in the lung. Am Rev Respir Dis1987;136:1207–1212.
39.
EspositoAL. Digoxin disrupts the inflammatory response in experimental pneumococcal pneumonia. J Infect Dis1985;152:14–23.
40.
BoneRC, FisherCJJr, ClemmerTP, SlotmanGJ, MetzCA, BalkRA, and the Methylprednisolone Severe Sepsis Study Group. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med1987;317:653–658.
41.
Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med1987;317:659–665.
42.
ReinarzJA, PierceAK, MaysBB, SanfordJP. The potential role of inhalation therapy equipment in nosocomial pulmonary infection. J Clin Invest1965;44:831–839.
43.
BoyceJM, WhiteRL, SpruillEY, WallM.Cost-effective application of the Centers for Disease Control guideline for prevention of nosocomial pneumonia. Am J Infect Control1985;13:228–232.
44.
GreenfieldS, TeresD, BushnellLS, Hedley-WhyteJ, FeingoldDS. Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients. J Clin Invest1973;52:2935–2940.
45.
KlickJM, du MoulinGC, Hedley-WhyteJ, BushnellLS, FeingoldDS. Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients. J Clin Invest1975;55:514–519.
46.
FeeleyTW, du MoulinGC, Hedley-WhyteJ, BushnellLS, FeingoldDS. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med1975;293:471–475.
47.
CrouchTW, HiguchiJH, CoalsonJJ, JohansonWGJr. Pathogenesis and prevention of nosocomial pneumonia in a nonhuman primate model of acute respiratory failure. Am Rev Respir Dis1984;130:502–504.
48.
SottileFD, MarrieTJ, ProughDS, . Nosocomial pulmonary infection: Possible etiologic significance of bacterial adhesion to endotracheal tubes. Crit Care Med1986;14:265–270.
49.
PalmerDL. Microbiology of pneumonia in the patient at risk. Am J Med1984;76:53–60.
50.
NiedermanMS. Strategies for the prevention of pneumonia. Clin Chest Med1987;8:543–556.
51.
BaumgartnerJD, GlauserMP. Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient. Rev Infect Dis1987;9:194–204.
52.
PenningtonJE, PierGB, SadoffJC, SmallGJ. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia. Rev Infect Dis1986;8:S426–S433.
